Moderna stock crashes after leaked melanoma vaccine data
Statements (10 of 16)
- Bearish
Moderna shares sink after leaked cancer data missed expectations
- Bearish
Moderna stock price fell 17.57% after reports of a possible data leak regarding a melanoma vaccine.
- Bearish
Moderna shares fell 18% after leaked trial results for its melanoma vaccine showed smaller risk reduction than earlier studies.
- Bearish
Moderna stock crashes due to leaked melanoma data threatening its record August rally
- Bearish
Moderna and Merck stocks fell after data on the melanoma vaccine was leaked.
- Bearish
Moderna stock price fell 24% after unverified leaks about its melanoma vaccine
- Bearish
Moderna, a pharmaceutical company, is facing a near 25% drop on Wall Street due to a leaked study on social media.
- Bearish
Moderna shares fell after a leak of cancer vaccine data despite positive results.
- Bearish
Moderna's stock tumbles after reported leak of data for cancer vaccine
- Bearish
Moderna shares fell 25% after a melanoma vaccine data report appeared online and vanished within hours.
6 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=e5e233fc-7fcd-456e-a9a7-24b4f81398f3 Get a free API key ↗